Nanoparticles could deliver drugs to the brain
For patients with malignant brain tumors, the prognosis remains dismal. With the most aggressive treatments available, patients are usually only expected to live about 14 months after a diagnosis.
This is because, chemotherapy, the most common form of treatment for cancer, is uniquely challenging for brain tumor patients. The delicate organ in our skulls is protected by a network of vessels and tissue called the blood-brain barrier that keeps most foreign substances out. Furthermore, chemotherapy drugs can cause significant damage to the rest of the body if they are not able to target the tumor in a pharmacologically significant dose.
These challenges have plagued scientists for years, but a team of researchers for Yale School of Medicine and Beijing Normal University just published a breakthrough study detailing a new method that offers a promise at treatment. The solution? Nanoparticles.
Nanoparticles, particles that are smaller than wavelengths of visible light and can only be seen under a special microscope, have the potential to pass through the blood-brain barrier. They can also carry drugs to targeted areas of the body, reducing the side effects on the rest of the body. But previous nanoparticles were very complex and not very efficient in penetrating in the brain.
This most recent paper, published in Nature Biomedical Engineering on March 30, 2020, describes a small carbon nanoparticle engineered by the two labs that could both deliver chemotherapy drugs across the blood-brain barrier and mark tumor cells with fluorescence in mice. What’s more, this nanoparticle is incredibly simple—made up of only one single compound.
We created nanoparticles like building a missile. There’s usually a GPS on every missile to guide it into a specific location and we’re able to guide particles to penetrate the brain and find tumors.
“The major problems we’ve solved is to improve the delivery efficiency and specificity of nanoparticles,” says Jiangbing Zhou, PhD, associate Professor of Neurosurgery and of Biomedical Engineering at Yale School of Medicine. “We created nanoparticles like building a missile. There’s usually a GPS on every missile to guide it into a specific location and we’re able to guide particles to penetrate the brain and find tumors.”
The GPS-like targeting occurs because the nanoparticles engineered to be recognized by a molecule called LAT1, which is present in the blood-brain barrier as well as many tumors, but not in most other normal organs. As a result, chemotherapy drugs can be loaded on the dots and target tumors while barely affecting the rest of the body. The nanoparticles gain entry to the brain because they’ve been engineered to look like amino acids, which are allowed past the blood-brain barrier as nutrients.
The nanoparticles have wider implications than drug delivery. They can be stimulated to emit a fluorescence, which helps surgeons locate tumor to remove with greater accuracy.
Still, there’s a long road ahead before this research can be applied in a clinical setting, says Dr. Zhou. “It takes a long time before the technology can be translated into clinical applications,” he says. “But this finding suggests a new direction for developing nanoparticles for drug delivery to the brain by targeting LAT1 molecules.”
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Brain cancer treatment
- Rutherford mayor to step down temporarily after revealing he has brain tumoron April 23, 2021 at 1:18 am
RUTHERFORD — Mayor Frank Nunziato will temporarily step down from his elected duties while he undergoes treatment for a brain tumor. 5 ways to keep your quarantine workout routine going as you head ...
- ‘I’m really happy’: Spokane teen with terminal brain cancer graduates earlyon April 22, 2021 at 6:56 pm
The tumor was growing on a part of his brain that cannot be touched. Since then, Jaden was going through treatment for cancer, even shrinking the tumor. As he was battling the brain tumor for the last ...
- Biocept Announces Full Commercial Launch of CNSide™ Cerebrospinal Fluid Assay to Address Unmet Needs for Patients with Metastatic Brain Canceron April 21, 2021 at 5:17 am
Biocept, Inc. (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products and services, has announced the full commercial launch of CNSide™, its cerebrospinal fluid (CSF) assay ...
- ZAP Surgical Announces Future Installation of Novel Non-Invasive Brain Tumor Treatment System in Munich, Germanyon April 20, 2021 at 7:12 am
ZAP Surgical Systems, Inc. today announced the upcoming installation of its advanced ZAP-X® Gyroscopic Radiosurgery® platform at the European CyberKnife® Center in Munich, Germany. Having recently ...
- 2021-2026 Global Brain Cancer Treatment Market Demand by Regions |Ono Pharmaceutical Co Ltd., Pfizer, Bayer AG and IMPACT Therapeutics Incon April 16, 2021 at 1:49 am
Brain Cancer Treatment market research report is a core study of the current scenario of the industry. An in-depth analysis of Brain Cancer Treatment market done by our professional and expert team.
Go deeper with Google Headlines on:
Brain cancer treatment
Go deeper with Bing News on:
Carbon nanoparticle drug delivery
- Sirnaomics' Spin-Off RNAimmune Secures $10 Million Seed Financing to Advance its mRNA-Based Vaccine and Therapeutic Developmenton April 21, 2021 at 7:00 pm
GAITHERSBURG, Md. and GUANGZHOU, China, April 21, 2021 /PRNewswire/ -- RNAimmune, Inc., a biopharmaceutical company specializing in discovery and ...
- PhD Oral Exam - Jun-Ray Macairan, Chemistry and Biochemistryon April 13, 2021 at 9:00 am
Recent advancements in the field of nanomaterials have propelled research groups into investigating these nanoparticles for various biological applications including drug delivery ... Recently, carbon ...
- Nanofibers for Medical and Cosmetics Market Size Forecast to Reach $4.2 Billion by 2026on April 12, 2021 at 3:05 pm
The Increasing Demand From Medical Industry Driving the Growth of Nanofibers for Medical and Cosmetics Market. The Nanofibers for Medical and Cosmetics Market size is forecast to reach $4.2 billion by ...
- Quantum Dots and Carbon Nanotubes in Oncologyon April 3, 2021 at 5:00 pm
Despite such undeniable contribution, the combination of functionalized CNTs and QDs for other biomedical applications is severely under-represented; for example, drug delivery of small molecules ...
- The Importance of Carbon Nanotube Surface Roughnesson April 2, 2021 at 11:57 am
Carbon nanotubes offer structural and mechanical properties that are advantageous to these applications, while they are highly useful as composites in tissue engineering. Research has demonstrated ...